Phase II trial of cisplatinum and etoposide in brain metastases of solid tumors

Journal of Neuro-Oncology

Volumn 35, Issue 2, 1997, Pages 145-148

  Vinolas N ^a   Graus, F ^a   Mellado, B ^a   Caralt, L ^a   Estape J ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Brain metastases; Chemotherapy; Treatment

Indexed keywords

CISPLATIN; ETOPOSIDE;

ADULT; AGED; ANEMIA; ARTICLE; BRAIN METASTASIS; BREAST TUMOR; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COLON TUMOR; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; LUNG TUMOR; MALE; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; SOLID TUMOR; STOMACH TUMOR; SURVIVAL TIME; THROMBOCYTOPENIA;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CISPLATIN; ETOPOSIDE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0030744082     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005835430489     Document Type: Article

References (23)

1. Buckner J: Surgery, radiation therapy and chemotherapy for metastatic tumors to the brain. Curr Opin Oncol 4:518-524, 1992
2. Posner J: Management of central nervous system metastasis. Semin Oncol 4: 81-91, 1977
3. Zimm S, Wampler GL, Stalbein D, Hazra T, Young HF: Intracerebral metastasis in solid tumor patients: Natural history and results of treatment. Cancer 48: 384-394, 1981
4. Duran RE, Goldie JH: Interaction of etoposide and cisplatin in an in vitro tumor model. Cancer Treat Rep 71: 673-679, 1987
5. Litterst CL, Le Roy AF, Guarino AM: Disposition and distribution of platinum following parenteral administration of cisdichlorodiamino platinum to animals. Cancer Treat Rep 63: 1485-1493, 1979
6. Holthuis JJM, Postmus PE, Oort WVJ, Hulshoff B, Verleun H, Sleijfer DT, Mulder NH: Pharmacokinetics of high dose of etoposide. Eur J Cancer Oncol 22:1149, 1986
7. Kiya K, Uozumi T, Ogasawara H, Sugiyama K, Hotta T, Mikami T, Kurisu K: Penetration of etoposide into human malignant brain tumors after intravenous and oral administration. Cancer Chemother Pharmacol 26: 339-342, 1992
8. Cocconi B, Lottici R, Biosagni G, Bacchi M, Tonato M, Passalacqua R, Boni C, Belsanti V, Bassi P: Combination therapy with platinum and etoposide of brain metastasis from breast carcinoma. Cancer Invest 8: 327-334, 1990
9. Kleisbauer JP, Guerin JC, Arnaud A, Poirier R, Vesco D: Chimiothérapie par cisplatine à forte dose dans les métastases cérébrales des cancers du poumon. Bull Cancer Paris 77: 661-665, 1990
10. Kolaric K, Roth A, Jelieie I, Matkovic A: Phase II clinical trial of cis dichlorodiamine platinum in metastatic brain tumors. J Cancer Clin Oncol 104: 287-293, 1982
11. Posmus PC, Haaxma Reiche H, Sleifer DT, Kirkpatrick A, Mclie JE: High dose etoposide for brain metastases of small cell lung cancer. A phase II study. Br J Cancer 523: 254-256, 1989
12. Miller AB, Hoogstraten B, Staquet M, Winkler A: Reporting results of cancer treatment. Cancer 47: 20-214, 1981
13. Kaplan GL, Meier P: Non parametric estimations for incomplete observations. Am Statist Ass J 53: 457-481, 1958
14. Simon R: Confidence interval for reporting results of clinical trials. Ann Intern Med 69: 269-273, 1986
15. Vlasveld LT, Beynen JH, Boogerd W, Ten Bokkel Huinink WW, Rodenhuis S: Complete remission of brain metastases of ovarian cancer following high-dose carboplatin: A case report and pharmacokinetic study. Cancer Chemother Pharmacol 25: 382-383, 1990
16. Boogerd W, Dalesio O, Bais EM, Van der Sande JJ: Response of brain metastases from breast cancer to systemic chemotherapy. Cancer 69: 972-980, 1992
17. Grau JJ, Estapé J, Daniels M, Mañé JM: BCNU Plusteniposide as a first line chemotherapy for brain metastasesregardless of their origin. Int J Cancer 4: 961-964, 1994
18. Jacquillat C, Khayat D, Banzet P, Weil M, Avril MF, Fumoleau P, et al.: Chemotherapy by fotemustine in cerebral metastases of disseminated malignant melanoma. Cancer Chemother Pharmacol 25: 163-266, 1990
19. Lange OF, Scheef W, Haase KD: Palliative radio-chemotherapy with ifosfamide and BCNU for breast cancer patients with cerebral metastases. Cancer Chemother Pharmacol 26 (suppl): 78-80, 1990
20. Robinet G, Bouva S, Clavier J, Richard P, Rouhart F, Mocquard Y, Goas JY: Chimiothérapie par cisplatine et 5-fluorouracil dans les métastases cérébrales inopérables des cancers broncopulmonaires. Bull Cancer 78: 831-837, 1991
21. Rosner D, Nemoto T, Pickren J, Lane W: Management of brain metastases from breast cancer by combination chemotherapy. J Neur Oncol 1: 131-137, 1983
22. Rustin GJS, Newlands ES, Bagshawe KD, Begent RHJ, Crawford M: Successful management of metastatic and primary germ cell tumors in the brain. Cancer 57: 2108-2113, 1986
23. Borgelt B, Gelber R, Kramer S, et al.: The palliation of brain metastases: Final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 6: 1-9, 1980